OPA1 and myocardial infarction: Recently, both in vivo and in vitro studies have revealed that optic atrophy 1 (Opa1) expression is downregulated in infarcted heart, whereas irisin treatment upregulated the expression of Opa1 and protects cardiomyocytes from further damage following MI (Xin and Lu, 2020).